Urodynamics testing requires very well-trained staff in order to determine the basis and progression of urologic diseases. Typically, UDS training is provided by the equipment manufacturers, but there are other viable training options in the market.

2018 Urology Practice Trends and Facts Infographic

In the following article we focus on this study and discuss the effects of the uroselective α1-blocker tamsulosin on urodynamic parameters in male patients with type I primary bladder neck obstruction. Moving forward, an obstruction with high voiding pressure accompanied by poor flow and narrowing at the neck of the bladder with concomitant silent external sphincter on electromyography forms the basis for primary bladder neck obstruction. Alpha blockers, which are used in the treatment of primary bladder neck obstructions do not have evidence for objective urodynamic efficacy.

Let’s delve into the topic. Available treatment options for bladder neck obstruction are observation of the patient with follow-up, clean intermittent catheterization or bladder neck incision, alpha blockers. Studies conducted to assess the efficacy of the pharmacological approach are nonrandomized and small.

2018 Urology Infographic -  Current Urology Practice Trends and Facts

The storage and elimination of urine are regulated by neural circuits in the brain and spinal cord to coordinate function between the urethra and the urinary bladder. During micturition, the elimination of urine is facilitated by bladder wall contraction as well as urethral wall and pelvic floor muscle relaxation. In the following article, we will discuss discuss this study: Randomized Controlled Trial to Assess the Impact of Intraurethral Lidocaine on Urodynamic Voiding Parameters.

Lower urinary tract symptoms (LUTS) lead to incomplete bladder emptying, decreased quality of life, increased healthcare use, decreased workplace productivity and impact in intimate relationships. Some of the approaches to improve the condition such as

Fecal incontinence (FI) is a common clinical condition with a negative impact on the quality of life. Commonly performed tests to evaluate fecal incontinence include anorectal manometry (ARM) and endoanal ultrasonography (EAU). In the following article, we will discuss this study, which aims to compare the results of these two tests in a cohort of patients with FI.

Fecal incontinence is defined as the involuntary passage of stool in a person older than 4 years and for a period of 3 months or more. The prevalence is suspected to be more than 15%, with higher incidence in the geriatric age population.

FI: Main Causes

Introduction:

Urodynamics (UDS) is an interactive diagnostic study of lower urinary tract function. It is composed of several tests that can be used to obtain functional information about urine storage and expulsion. Its main goal is to reproduce the patients’ symptoms and determine their cause.

The present article is a review of the physiological concepts behind UDS, and explains the various normal and abnormal forces and parameters that are measured and used during the tests to assist the physician in making a diagnosis. It outlines the importance and methods of the calibration of UDS equipment to optimize diagnostic accuracy and reliability, which would have a crucial impact over the treatment’s decision, and consequently the patient’s outcome.

 Anorectal function tests are usually performed in patients with fecal incontinence who have failed typical, conservative treatment. This study, which we are going to discuss right now, was aimed to determine the additive value of performing anorectal function tests in such patients in selecting them for surgery.

Introduction

Fecal incontinence is the inability to voluntarily control bowel movements causing stool to leak from the rectum, unexpectedly. It is a very disabling condition with a prevalence of roughly 6% in the adult population. Causes of FI are:

• Disruption of the anal sphincters secondary to obstetric or surgical trauma;
• Neuropathy such as multiple sclerosis diabetes mellitus;
• Neurologic deterioration related to nervus pudendus injury due to chronic straining during chronic constipation or delivery
• Decreased rectal capacity due to inflammatory bowel disease, radiation proctitis and/or irritable bowel syndrome, diarrhea, the physical inability to reach toilet facilities, and highly reduced mental awareness.

The following article is based on a study which addresses the evidences available in the medical literature on the efficacy of Botulinum Toxin A (BoNT-A) and sacral neuromodulation (SNM) in patients suffering from interstitial cystitis (IC)/bladder pain syndrome (BPS). We will discuss this study to identify the mechanism of action and draw a clear conclusion based on the clinical efficacy of both therapies.

Introduction

The terms interstitial cystitis and bladder pain syndrome are used side by side. IC/BPS is often used like this in the medical world, boasting symptoms such as urinary frequency, urgency and bladder pain, pressure and/or discomfort in the absence of other pathological findings. Current management aims to decrease symptoms such as bladder pain and lower urinary tract (LUT) symptoms.

In the following article we are going to summarize this study. The aim of this research paper is to present facts and data to state that simultaneous pressure measurements with WP and AC in a single catheter will provide analogous pressures for Valsalvas, coughs, and maximum pressures in voiding pressure studies (VPS).